Supplemental Indications

5 result(s)
Drug Pipeline
Specialty Drug Pipeline: 2018 Year in Review
An overview of recently approved therapies, anticipated approvals in the year to come, and strategies to help manage the pipeline More
Feature
Two female pharmaceutical scientists working in a lab
Drug Pipeline
Supplemental Indications Add Uses, Expand Market
When the FDA approves a “supplemental indication” for a drug already on the market — permitting it to be used for new conditions or stages of a disease, or additional patient... More
Briefing
Lady suffering from migraine, pressing hand against forehead
Drug Pipeline
Migraine Relief in Sight?
The market for migraine medications is ripe for growth due to a large patient population with an unmet clinical need. Four investigational medications known CGRP inhibitors will... More
Feature
Senior canoeist outdoors
Specialty
Potential Market Expansion for Prostate Cancer Drug
Blockbuster cancer drug Zytiga may become first-line treatment for patients with metastatic, castration-resistant cancer, greatly expanding its market and cost impact. More
Feature
Icon of Rx prescription script
Specialty
Supplemental Indications
The U.S. Food and Drug Administration (FDA) approves drugs for specific indications, or uses. The indication identifies the condition(s) a drug is approved to treat, and it may... More
Feature